[MRT of brain metastases. (I) What is the place of screening with T2-weighted sequences?]

Rofo. 1990 Sep;153(3):321-6. doi: 10.1055/s-2008-1033385.
[Article in German]

Abstract

Sensitivity and specificity of plain T2-WI and Gd-DTPA enhanced T1-WI were compared by evaluating MR exams of 30 patients with brain metastases. Large lesions with high signal on T2-WI always enhanced (43/43) when a structure (perifocal edema, tumor tissue, central necrosis) was found. Large lesions nearly always enhanced (53/55) even if no such structure was found. 65% of small unstructured white matter lesions with high signal on T2-WI, which are generally considered vascular, did not enhance. Surprisingly, 35% did enhance. Demonstration of blood brain barrier disturbance in these lesions suggested a metastatic origin. In 3 patients with multiple metastases, Gd-DTPA enhanced T1-WI disclosed more than 140 lesions not seen on T2-WI. All of them were located in or adjacent to grey matter. Our results indicate that enhanced T1-WI should be obtained even if T1-WI are normal or show only small white matter lesions.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / secondary*
  • Breast Neoplasms / diagnosis
  • Carcinoma, Bronchogenic / diagnosis
  • Gadolinium
  • Gadolinium DTPA
  • Gastrointestinal Neoplasms / diagnosis
  • Humans
  • Lung Neoplasms / diagnosis
  • Magnetic Resonance Imaging*
  • Male
  • Melanoma / diagnosis
  • Middle Aged
  • Organometallic Compounds
  • Pentetic Acid

Substances

  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA